Shri Ram Murti Smarak Institute of Medical Sciences is a private medical college located near Bareilly in Bareilly district, Uttar Pradesh, India. The college affiliated to M. J. P. Rohilkhand University, Bareilly was established in 2002.
Problem considered From maps to medicine, geospatial epidemiology offers a powerful lens to visualize cancer distribution and translate spatial insights into actionable healthcare planning. Gastrointestinal (GI) and Hepatopancreatobiliary (HPB) Cancers pose a significant burden in India, yet fine-scale spatial mapping remains underutilized for cancer control planning. Methods This was a retrospective record-based study of 1,544 patients with Gastrointestinal /Hepatopancreatobiliary Cancers treated at a tertiary cancer centre in Rohilkhand region, Uttar Pradesh (January, 2013- August, 2025). Demographic, tumor site, and clinical outcome data were analyzed. Residential addresses were geo-coded to block level, and Spatial clustering of hospital-treated cases were identified using Local Moran’s I statistics. Results The median age of patients was 53 years (IQR 44–62), with nearly equal sex distribution. HPB cancers accounted for 56% of cases, of which Gallbladder carcinoma was the most frequent (43%) with female predominance (69.7%). Patients predominantly came from district Bareilly 703(46%), Shahjahanpur 214(14%), and Pilibhit 198 (13%). Among 75 blocks analyzed, 2 (2.6%) showed significant clustering of hospital-treated GI cancer cases. For HPB cancers, 4 (5.3%) blocks in Bareilly and 3 (4%) blocks in Rampur demonstrated significant clustering (p < 0.05). Conclusion This study concludes spatial heterogeneity in the distribution of hospital-treated GI/HPB cancer cases in the Rohilkhand region, with a predominance of gallbladder carcinoma. Identified clusters represent spatial concentrations of patients presenting to a tertiary care center and should be interpreted as descriptive/hypothesis-generating. These findings may inform future studies and more detailed investigations incorporating population denominators and environmental/healthcare access factors.
Background:Telomeres are protective DNA sequences at chromosome ends that shorten with cell division and regulate cellular lifespan. Dysregulation of telomere maintenance through telomerase activation is implicated in carcinogenesis, including ovarian cancer. This study aimed to systematically review and meta-analyze the association between telomere length and ovarian cancer risk and survival outcomes. Methodology:A systematic search of PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library was conducted from inception to the final search date. Studies evaluating measured telomere length in relation to ovarian cancer risk or survival were included. Eligible observational studies reporting effect estimates were pooled using random-effects meta-analysis. Odds ratios (ORs) were synthesized for ovarian cancer risk, while hazard ratios (HRs) were pooled for survival outcomes. Heterogeneity was assessed using Cochran's Q test and the I 2 statistic. Results:Eleven studies were included in the systematic review, of which seven were eligible for meta-analysis (four risk studies and three survival studies). For ovarian cancer risk, the pooled common-effect estimate showed a modest association (OR = 1.17; 95% confidence interval [CI]: 1.02-1.34), but this was not statistically significant under the random-effects model (OR = 1.23; 95% CI: 0.70-2.16) with moderate heterogeneity (I 2 = 66.8%, P = 0.0287). For survival outcomes, the common-effect model showed no significant association between telomere length and survival (HR = 0.98; 95% CI: 0.83-1.16), with substantial heterogeneity (I 2 = 85.2%, P = 0.001). The random-effects estimate also showed no significant association (HR = 1.66; 95% CI: 0.21-12.87). Conclusions:Current evidence does not demonstrate a consistent association between telomere length and ovarian cancer risk or survival. Substantial heterogeneity across studies highlights the need for large, well-designed prospective studies with standardized telomere measurement methods to clarify the role of telomere dynamics in ovarian carcinogenesis.
Background: Although vitamin C has been proposed to prevent complex regional pain syndrome (CRPS), evidence remains inconsistent. This study evaluated the effect of vitamin C on the incidence of CRPS-I in elderly patients with distal radius fractures. Methods: This prospective, non-randomised comparative study included elderly patients undergoing conservative or surgical treatment for distal radius fractures. Patients were allocated alternately to receive either oral vitamin C (500 mg/day) plus standard care or standard care alone for 3 months. Participants were followed for 9 months, and CRPS-I was diagnosed using the Budapest criteria. Results: CRPS-I developed in 15.5% (19/122) of the vitamin C group and 35.2% (43/122) of the control group. The difference was statistically significant (p = 0.021; OR 0.44, 95% CI 0.21–0.94). Vitamin C supplementation significantly reduced the likelihood of developing CRPS-I. Conclusions: Vitamin C supplementation (500 mg/day) was associated with a lower incidence of acute CRPS-I following distal radius fractures. It may represent a simple, inexpensive preventive strategy in elderly patients. Amongst patients who developed CRPS-I, vitamin C was also associated with better functional and quality-of-life outcomes. Level of Evidence: Level II (Therapeutic)
1. Sah, VK, & Prakash, S. Clinical profile of patients with acute kidney injury admitted in intensive care unit. International Journal of Advances in Medicine, 2022;9: 532–536. https://doi.org/10.18203/2349-3933.ijam20221087 2. Gleeson PJ, Crippa IA, Sannier A, Koopmansch C, Bienfait L, Allard J, Sexton DJ, Fontana V, Rorive S, Vincent JL, Creteur J, Taccone FS. Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology. Clin Kidney J. 2023 May 22;16(10):1664-1673. doi: 10.1093/ckj/sfad113. 3. Ballah A, Mohammed J, Njidda GA, et al. Outcome and Determining Characteristics of ICU Patients with Acute Kidney Injury in a Low-Income Country, a Multicenter Experience. J Crit Care Med (Targu Mures). 2024 Oct 31;10(4):345-352. doi: 10.2478/jccm-2024-0037. 4. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007 Apr;18(4):1292-8. doi: 10.1681/ASN.2006070756. 5. Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009 Oct;35(10):1692-702. doi: 10.1007/s00134-009-1530-4. 6. Korula S, Balakrishnan S, Sundar S, Paul V, Balagopal A. Acute kidney injury-incidence, prognostic factors, and outcome of patients in an Intensive Care Unit in a tertiary center: A prospective observational study. Indian J Crit Care Med. 2016 Jun;20(6):332-6. doi: 10.4103/0972-5229.183904. 7. Khambhala M V, Bhatt KN , Vasava KD, Chaudhary PB. A Retrospective Study of Outcomes of Acute Kidney Injury In the Medical Intensive Care Unit. JIACM 2025; 26 (3): 97-102 8. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015 Aug;41(8):1411-23. doi: 10.1007/s00134-015-3934-7. 9. Saini N, Bhattacharjee K. Spectrum and Outcome of Acute Kidney Injury in Nonsurgical Cardiac Intensive Care Unit Patients: A Prospective Observational Study. Indian J Crit Care Med. 2025 Jun;29(6):479-485. doi: 10.5005/jp-journals-10071-24990. 10. Kumar R, Katara S. Burden and predictors of anemia among children in Uttar Pradesh: Evidence from NFHS-5. Int J Agric Stat Sci. 2025; 21:627. doi:10.59467/IJASS.2025.21.627 11. Chawla LS, Abell L, Mazhari R, Egan M, Kadambi N, Burke HB, Junker C, Seneff MG, Kimmel PL. Identifying critically ill patients at high risk for developing acute renal failure: a pilot study. Kidney Int. 2005 Nov;68(5):2274-80. doi: 10.1111/j.1523-1755.2005.00686. x. 12. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM; Program to Improve Care in Acute Renal Disease. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004 Oct;66(4):1613-21. doi: 10.1111/j.1523-1755.2004.00927. x. 13. Mahmood N, Rahman MF, Rahman MM, Shahid SH, Siddiqui MM. Acute kidney injury in patients of intensive care unit. Anwer Khan Modern Med College J. 2017;8(1):38-44. 14. Bagshaw SM, George C, Bellomo R; ANZICS Database Management Committe. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008 May;23(5):1569-74. doi: 10.1093/ndt/gfn009. 15. Bhattacharjee K, Thakur CP, Das D. Spectrum of acute kidney injury in critically ill patients in medical ICU: A single center hospital-based study from North-Eastern India. JEBMH 2018; 5:893-97. DOI:10.18410/jebmh/2018/182 16. Melo FAF, Burdmann EA, Macedo E, Mehta R, Zanetta DMT. Acute kidney injury developed in the intensive care unit: a population-based prospective cohort study in the Brazilian Amazon. Sci Rep. 2024 Oct 3;14(1):22954. doi: 10.1038/s41598-024-74177-y. 17. Mathew DMK, Radha DTR. Etiological Factors and Clinical Profile of Acute Kidney Injury in Medical Intensive Care Unit. J Current Med Res Opinion [Internet]. 2019 Nov. 27 [cited 2026 May 5];2(11):350-66. Available from: https://www.cmro.in/index.php/jcmro/article/view/235 18. Eswarappa M, Gireesh MS, Ravi V, Kumar D, Dev G. Spectrum of acute kidney injury in critically ill patients: A single center study from South India. Indian J Nephrol. 2014 Sep;24(5):280-5. doi: 10.4103/0971-4065.132991.
Frontal sinus morphometry shows forensic promise for gender determination, yet paranasal sinus radiographs remain underexplored compared to CT-based assessments despite their accessibility. Therefore, it is of interest to evaluate frontal sinus dimensions (area, width, height) in 300 healthy adults (>20 years) using standardized paranasal sinus views with digital measurement techniques. Right frontal sinus height emerged as the most reliable predictor, achieving 69% accuracy for gender discrimination across all measured parameters. Paranasal radiographs demonstrated clinically viable predictive performance, particularly for height-based analysis compared with area- or width-based metrics. Thus, we document paranasal sinus views as a practical, cost-effective forensic tool for gender estimation when advanced imaging is unavailable.